MediPharm Labs Corp. (TSE:LABS – Get Free Report) reached a new 52-week low on Friday . The stock traded as low as C$0.06 and last traded at C$0.07, with a volume of 206733 shares. The stock had previously closed at C$0.07.
MediPharm Labs Stock Performance
The company has a debt-to-equity ratio of 5.90, a quick ratio of 3.10 and a current ratio of 3.11. The stock has a market cap of C$26.72 million, a price-to-earnings ratio of -1.63 and a beta of 0.88. The stock has a fifty day simple moving average of C$0.07 and a two-hundred day simple moving average of C$0.07.
About MediPharm Labs
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.
Read More
- Five stocks we like better than MediPharm Labs
- What is a buyback in stocks? A comprehensive guide for investors
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- How to Calculate Options Profits
- Bloom Energy: Powering the Future With Decentralized Energy
- ETF Screener: Uses and Step-by-Step Guide
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
